Results 201 to 210 of about 101,913 (345)

A mixed-methods study of patient perspectives on antiseizure medication discontinuation attempts after a period of seizure-freedom. [PDF]

BMJ Neurol Open
Terman SW, Silva JM, Kuster M, Lee J, Brand A, Manuel K, Kalia N, Dugan M, Reid M, Mortati K, Tolmasov A, Burke JF, Hill CE, Okula SS, Patel PS.   +14 more
europepmc   +1 more source

‘Mining women’ and livelihoods: Examining the dominant and emerging issues in the ASM gendered economic space [PDF]

George Ofosu, David Sarpong, Mabel Torbor, Shadrack Asante   +3 more
openalex   +1 more source

Seizure relapse in new onset epilepsy: It is not always drug resistance

Epilepsia, EarlyView.
Abstract Objective Seizure recurrence in new onset epilepsy (NOE) can result from various factors. Although drug ineffectiveness is frequently investigated, other causes—such as nonadherence, inadequate treatment, nonepileptic events (e.g., functional/dissociative), or acute symptomatic seizures—also impact patient outcomes.
Cecilia Catania, Eric Menetre, Aikaterini Fitsiori, Felix Tobias Kurz, Gabriela Moreno Legast, Serge Vulliemoz, Mathieu Genoud, Pierre Mégevand, Roland Wiest, Fabienne Picard, Sandor Beniczky, Margitta Seeck   +11 more
wiley   +1 more source

Preparation and Structural Characterization of Micron-Sized Natural Starch Microspheres via the Membrane Emulsification Method. [PDF]

ACS Omega
Pan W, Qiu D, Zhuang X, Zhang Y, Mao L, Zhang Z, Zuo R, Li T, Pei Z.   +8 more
europepmc   +1 more source

Differences in the ASM model caused by data structure

, 2018
Zbigniew Kowalewski
openalex   +1 more source

A translational multimodal machine‐learning prototype predicting valproate response in epilepsy treatment

Epilepsia, EarlyView.
Abstract Objective Epilepsy affects ~1% of the global population and often requires lifelong antiseizure medication (ASM) therapy. Valproic acid (VPA) is a commonly prescribed first‐line ASM, yet only approximately half of patients achieve sustained seizure freedom. Treatment selection remains largely empirical.
Simeon Platte, Afsheen Kumar, Giorgia Guerini, Massimo Pandolfo, Denise Haslinger, Colin B. Josephson, Guillermo Delgado‐García, Navprabhjot Kaur, Michaela‐Pauline Lux, Heiko Stempfle, Chantal Depondt, Reetta Kälviäinen, Felix Rosenow, Sophie von Brauchitsch, Karl Martin Klein, Andreas G. Chiocchetti   +15 more
wiley   +1 more source

Duration of anti-seizure medicines started for acute symptomatic seizures due to acute meningitis: a systematic review and meta-analysis. [PDF]

BMC Med
Prasad M, Kumar A, Couban R, Schiess N, Kothari K, Brohan E, Binello N, Venuti F, Dua T.   +8 more
europepmc   +1 more source

ASMS awards

Journal of the American Society for Mass Spectrometry, 2010
openaire   +1 more source

Clinical validation of a patient‐friendly saliva microsampling approach to monitor perampanel levels in people with epilepsy

Epilepsia, EarlyView.
Abstract Perampanel (PER) is a third‐generation antiseizure medication (ASM) with a well‐established concentration–effect relationship. Saliva represents a non‐invasive alternative to plasma for therapeutic drug monitoring (TDM) of PER, as it reflects the free plasma fraction.
Valentina Franco, Francesca Dattrino, Michela Palmisani, Federica Tacchella, Elena Tartara, Valentina De Giorgis, Carlo Alberto Quaranta, Ludovica Pasca, Paola Rota, Emilio Russo, Andrea Romigi, Cecilie Johannessen Landmark, Guido Fedele, Cristina Tassorelli, Pierluigi Nicotera   +14 more
wiley   +1 more source

Patterns of levetiracetam and lacosamide use for treatment of status epilepticus with respect to clinical features and prior antiseizure medications. [PDF]

BMC Neurol
Pöytäkangas T, Basnyat P, Saarinen J, Rainesalo S, Peltola J.   +4 more
europepmc   +1 more source